Brief: Aroa Biosurgery Says H1 Product Sales Revenue Was About NZ$17 Mln, Grew 108%

Aroa Biosurgery

06/10/2021 02:10

Oct 6 (Reuters) - Aroa Biosurgery Ltd  ARX.AX :
    * H1 FY22 PRODUCT SALES REVENUE OF ABOUT NZ$17 MILLION, 
GROWTH OF
108%
    * SIGNED A CONTRACT EXTENSION FOR ITS MYRIAD PRODUCTS WITH
HEALTHTRUST
    * SEES FY22 PRODUCT SALES REVENUE AT UPPER END OF PREVIOUSLY
ANNOUNCED GUIDANCE OF NZ$30 MILLION TO NZ$33 MILLION

Source text for Eikon:  ID:nASX5b2F2g 
Further company coverage:  ARX.AX 

 ((Reuters.Briefs@thomsonreuters.com;))